OBJECTIVE: This prospective study analyzed our experiences, including robot-assisted thyroidectomy via transaxillary approach (RTTA) and transoral robotic surgery (TORS), to evaluate feasibility and efficacy of robot-assisted surgery in the field of head and neck surgery. METHOD: The da Vinci robot (Intuitive Surgical Inc., Sunnyvale, CA) was used to carry out the operations. A total of 55 patients were enrolled in this prospective study, and it was approved by the IRB of Yonsei University. RESULTS: TORS was successfully performed in 52 patients. They include 13 cases of Robot-assisted lateral oropharyngectomy, 11 cases of partial hypopharyngectomy, 10 cases of base of tongue and oral cavity cancer resection, and 3 cases of parapharyngeal tumor resection. Robotic operation time was averaged at 76.6 minutes (range, 18-170 min), and the average amount of bleeding was measured as 13.3 ml (range, 5-40 ml). The decannulation of patients who received tracheotomy for the maintenance of the airway was done in an average of 5.1 days (range, 4-6 days) without any problem in phonation. Swallowing was possible within an average of 5.9 days (range, 1-12 days) in patients undergoing TORS. All margins were negative and no major complications were noted in TORS cases. In patients undergoing RTTA, the operation was successfully completed in all 3 cases and perioperative complication was not reported. CONCLUSION: The feasibility and safety of robot-assisted surgery in the field of head and neck surgery could be well ascertained. It enables minimal invasive surgery and reduces the patient's morbidity.
First Report on the Development and Validation of LSE-Scale
Raghav Dwivedi, MRCS, DOHNS, MRCPS, MS (presenter); Rehan Kazi, PhD OBJECTIVE: To develop and validate the FIRST ever speech-specific perceptual speech evaluation tool, the London Speech Evaluation scale (LSE-scale) for head and neck cancer (HNC) patients. METHOD: Following a literature review and discussion in a multidisciplinary setting, five speech parameters (intelligibility, articulation, speech rate, nasality and asthenia) and overall grade were identified. Speech samples of 117 subjects (65 consecutive follow-up oral and oropharyngeal cancer patients and 52 healthy volunteers) were recorded using a standard protocol consisting of reciting specific words and a standard text passage. All samples were independently judged and rated by three experienced raters and re-rated 12 weeks apart to establish intra-rater reliability. Internal consistency, intra-rater reliability and inter-rater reliability of different parameters of this scale and overall grade were determined using Cronbach's alpha and Spearman's rank correlation coefficients. Construct validity was tested using Spearman's rank correlation coefficient and Mann-Whitney U-test. RESULTS: The Cronbach's alpha coefficients for internal consistency ranged between 0.87-0.90 for connected speech and 0.79-0.84 for single words. The Spearman's correlation coefficients for intra-rater reliability of these parameters for connected speech and words varied between 0.38-0.87 and 0.50-0.71, respectively, while those for inter-rater reliability were between 0.55-0.99 and 0.40-0.57, respectively. For construct validity, the Spearman's correlation coefficient ranged between 0.41-0.55. CONCLUSION: LSE scale is a reliability and valid tool for speech evaluation in HNC patients. We believe that it will be a helpful adjunct in rehabilitation of HNC patients. This scale may also have some extended usage in the rehabilitation of neurological patients suffering from speech problems.
Gene Therapy for Head and Neck SCC Using KITENIN-Antisense
Joon Kyoo Lee, MD, PhD (presenter) OBJECTIVE: 1) Investigate the efficacy of gene therapy targeting KITENIN in human head and neck SCC. 2) Investigate the KIETNIN expression in SNU-1041 head and neck SCC cell line. METHOD: SNU-1041, a well-established human head and neck SCC cell line, was used. KITENIN expression in SNU-1041 was measured by Western blot analysis. The cells were prepared and maintained in culture dishes with media, divided into two groups: the si-KITENIN group and the scrambled group (control). The siRNA targeting KITENIN (si-KITENIN) and scrambled DNA were transfected into the SNU-1041 cells in each group. The effect of gene therapy was compared by in vitro experiments evaluating: invasion, migration, and proliferation. RESULTS: KITENIN was strongly expressed in the SNU-1041 cells. For the invasion evaluations, the invaded cells were reduced more in the si-KITENIN group than in the scrambled group (pϽ0.001). The speed for the narrowing gap, made through adherent cells, was lower in the si-KITENIN group (pϽ0.001). The number of viable proliferating cells was reduced in the si-KITENIN group compared to the scrambled group (pϽ0.001, the third day). KITENIN protein expression was no longer identified in the si-KITENIN group. CONCLUSION: Gene therapy using an anti-KITENIN strategy might be effective for head and neck squamous carcinoma.
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